Ardent Health

ARDT

Börsenwert 1,69 Mrd. $

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2026 results after the market closes on Wednesday, Nov. 4, 2026. A conference call will be held the following day, Thursday, Nov. 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presen.

Ardent Health remains a 'buy' as shares are deeply undervalued despite recent profitability declines. ARDT revenue continues to grow, with management projecting $6.4–$6.7 billion for the year, but EBITDA and cash flow are expected to fall short of prior results. Professional fees pressured margins, but management anticipates this cost trend will moderate in the second half, signaling potential stabilization.

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that 13 hospitals across its network earned recognition in U.S. News & World Report's 2026-2027 Best Hospitals rankings, the publication's 37th annual assessment of hospital quality. The honors include a Best Regional Hospital designation, regional specialty rankings and 34 High Performing ratings across procedures and conditi.

BRENTWOOD, Tenn. & TYLER, Texas--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler – the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, orthope.

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, in Boston, Massachusetts. Members of the management team will participate in a fireside chat on September 9, 2026, at 11 a.m. ET. A live audio webcast of the event will be available in the Investor Relations sec.

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

BRENTWOOD, Tenn. & TULSA, Okla.--(BUSINESS WIRE)--Oklahoma Heart Institute (OHI), part of Hillcrest HealthCare System and Ardent Health (NYSE: ARDT), is now the only site in Oklahoma and the surrounding region participating in several leading national cardiovascular trials – and recently became the first in the United States to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II clinical trial. Through this research, OHI is expanding acces.

ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.

Ardent Health NYSE: ARDT reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than-expected volumes.